Kathleen S. Wright Associates’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-300
Closed -$16.9K 255
2024
Q4
$16.9K Hold
300
0.01% 203
2024
Q3
$20.4K Hold
300
0.01% 206
2024
Q2
$12.7K Sell
300
-200
-40% -$11K 0.01% 188
2024
Q1
$34.5K Hold
500
0.02% 147
2023
Q4
$37K Hold
500
0.02% 130
2023
Q3
$34.1K Hold
500
0.02% 128
2023
Q2
$47K Buy
+500
New +$39K 0.03% 109

Other funds holding EXAS

Kathleen S. Wright Associates's EXAS Position: Q1 2025 in Review

Kathleen S. Wright Associates sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 300 shares — an estimated $16.9K sold.

Kathleen S. Wright Associates first reported a position in EXAS in Q2 2023 and held it in 7 quarters. The position peaked at $47K in Q2 2023. 556 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Kathleen S. Wright Associates reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • Kathleen S. Wright Associates sold 300 Exact Sciences shares in Q1 2025, an estimated $16.9K.
  • Kathleen S. Wright Associates first reported a position in Exact Sciences in Q2 2023 and held it in 7 quarters.
  • Kathleen S. Wright Associates's Exact Sciences position peaked at $47K in Q2 2023.
  • 556 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Kathleen S. Wright Associates's 13F filing for Q1 2025, filed 6 May 2025.